A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) ...

Aspyre Lung is a targeted biomarker panel of 114 genomic variants across 11 guideline-recommended genes with simultaneous DNA and RNA for non–small cell lung cancer (NSCLC). In this study, we ...

Comparative analysis of immunotherapy treatments in non-small cell lung cancer (NSCLC) using novel causal machine learning approaches.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a proposed collaboration with Guardant Health, I ...

Researchers say findings provide compelling evidence underscoring the potential of electric-field molecular fingerprinting for minimally invasive disease detection.

“This certainly changes things big time,” Dr. Vivek Yadav said. “Because approximately 50% of lung cancer is diagnosed when it’s already metastasized to different parts of the body and it ...

Conway Medical Center is using new robotic-assisted technology aimed at detecting lung cancer earlier and with greater ...

Edgardo S. Santos, MD, FACP, FASCO, emphasized the need to eliminate the stigma around smoking in lung cancer, highlighted the importance of early detection and discussed how advances in precision ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had low-dose CT screening, in London.